Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricTEVATeva Pharmaceutical Industries LtdZTSZoetisHLNHaleon PLC
Snapshot
Price$31.46$75.45$9.95
Market cap$32.95B$33.26B$40.75B
Valuation
P/E25.8x12.1x19x
Forward P/E—11.1x16.2x
Growth
Revenue growth4.4%2.4%-1.8%
EPS growth—8.4%17.6%
Profitability
Net margin9.0%27.8%15.1%
ROE20.7%62.4%10.3%
Balance sheet & cash
Debt / equity2.12x2.72x0.52x
Free cash flow yield-10.5%7.5%0.5%
Dividend yield—1.6%1.9%
Verdict
Investment ratingWeak· 33Favorable· 63Neutral· 48

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearTEVAtoday $31ZTStoday $75HLNtoday $10
2027$24.64 – $36.13+15% CAGR$61.34 – $89.96+19% CAGR$8.77 – $12.87+29% CAGR
2028$25.72 – $37.73+10% CAGR$66.48 – $97.51+14% CAGR$10.32 – $15.13+23% CAGR
2029$26.86 – $39.39+8% CAGR$72.06 – $105.69+12% CAGR$12.13 – $17.79+21% CAGR
2030$28.04 – $41.13+7% CAGR$78.10 – $114.55+11% CAGR$14.26 – $20.91+20% CAGR
2031$29.28 – $42.94+6% CAGR$84.66 – $124.16+10% CAGR$16.76 – $24.59+20% CAGR
5-yr CAGR-1.4% – 6.4%2.3% – 10.5%11.0% – 19.8%